Altimmune ALT 深 沪
已收盘 02-06 16:00:00 美东时间
4.87
-0.050
-1.02%
华盛通- 最 高5.085
- 今 开5.00
- 成交量 384.48万股
- 最 低 4.84
- 昨 收 4.92
- 总市值 6.10亿
- 52周最高 7.73
- 市盈率 静 --
- 换手率 3.07%
- 52周最低 2.90
- 委 比 -56.23%
- 总股本 1.25亿
- 历史最高 237.30
- 量 比 0.82
- 振 幅 4.98%
- 历史最低 1.51
- 每 手 1
- 风险率 1.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Obesity stocks slump on Novo's underwhelming 2026 sales forecast
Obesity stocks slump on Novo's underwhelming 2026 sales forecast Feb 3 (Reuters) - Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk NOVOb.CO forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the blockbuster weight-loss mar
02-04 02:23
BUZZ-US-listed Novo shares slip after company flags sharp 2026 sales drop
BUZZ-US-listed Novo shares slip after company flags sharp 2026 sales drop ** U.S.-listed shares of Danish drugmaker Novo Nordisk NOVOb.CO fall 13.8% to $50.83 ** Novo expects 2026 sales to fall between 5% and 13%, as competition in obesity drugs intensifies; analysts on average expect sales to decli
02-04 01:48
UPDATE 3-Novo Nordisk warns on profits and sales amid Trump drug price crackdown
UPDATE 3-Novo Nordisk warns on profits and sales amid Trump drug price crackdown Novo says 2026 sales, operating profit may fall as much as 13% Analysts had expected a 2% sales decline this year CEO optimistic about Wegovy pill's early US market uptake US, product chiefs leave in latest management r
02-04 01:15
Altimmune (ALT) Shares Slide On $75 Million Stock Offering
Altimmune shares are tumbling on Wednesday following the company's announcement of a $75 million registered direct offering of common stock.
01-29 05:13
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers ENvue Medical (NASDAQ:FEED) stock moved upwards by 19.0% to $1.25 duri...
01-28 20:05
Altimmune (ALT) Raises $75M to Boost Obesity Drug Pipeline
Altimmune ($ALT) has raised $75 million in new funding, giving the biotech comp...
01-28 16:09
Altimmune prices $75M direct offering
Altimmune (ALT) entered into a securities purchase agreement with a new fundamental institutional investor for the purchase and sale of 17.05M shares pursuant to a registered direct offering. The offe...
01-28 12:39
Altimmune Raises $75 Million in Direct Offering of Shares and Pre-Funded Warrants
Altimmune Raises $75 Million in Direct Offering of Shares and Pre-Funded Warrants Altimmune Inc. has announced a registered direct offering involving the sale of 17,045,454 shares of its common stock or pre-funded warrants in lieu thereof, to a new institutional investor. The offering is expected to
01-28 10:25
Altimmune Announces Pricing of $75 Million Registered Direct Offering of Common Stock
Altimmune, a late clinical-stage biopharmaceutical company, has entered into a securities purchase agreement with a new institutional investor for the sale of 17,045,454 shares of common stock, expected to raise approximately $75 million. The funds will be used to prepare for its upcoming Phase 3 trial for pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH) and for general corporate purposes. The offering is expected to close o...
01-28 02:25
Booz Allen Posts Upbeat Q3 Earnings, Joins Life360, Redwire And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Dow Jones falling around 200 points on Friday....
01-23 23:55
